Clinical Trials Directory

Trials / Completed

CompletedNCT04449952

A Study of Mouth Rinses in Type 1 and Type 2 Diabetic Participants

Safety and Clinical Efficacy of Mouth Rinses in Type 1 and Type 2 Diabetics: Effect on Oral Soft Tissue, Plaque and Gingivitis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
154 (actual)
Sponsor
Johnson & Johnson Consumer Inc. (J&JCI) · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate mouth rinse formulations for oral soft tissue tolerance and efficacy in plaque/ gingivitis prevention/reduction in Type 1 and Type 2 diabetics when used twice daily as an adjunct to tooth brushing during a twelve-week treatment period.

Conditions

Interventions

TypeNameDescription
OTHERListerine Cool MintParticipants use 20 mL of Listerine cool mint mouth rinse for 30 sec after brushing
OTHER5% Hydroalcohol Mouth RinseParticipants use 20 mL of 5% Hydroalcohol mouth rinse for 30 sec after brushing.
OTHERColgate Cavity Protection ToothpasteParticipants used Colgate cavity protection toothpaste for brushing teeth twice daily.
OTHERAlcohol-Free Essential Oil Containing (AFEO) Mouth Rinse Lead FormulaParticipants use 20 mL of AFEO mouth rinse lead formula for 30 sec after brushing.
DEVICEConcept Curve Winter Series ToothbrushParticipants will brush teeth at least one minute with provided bristled toothbrush.
DEVICEListerine Cool Mint FlossParticipants will use marketed fluoride-containing dentifrice, floss.

Timeline

Start date
2019-12-02
Primary completion
2020-03-06
Completion
2020-03-06
First posted
2020-06-29
Last updated
2023-08-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04449952. Inclusion in this directory is not an endorsement.